Electromedical Technologies, Inc.
EMED · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -56.4% | 17.3% | 26.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 64.8% | 77.5% | 77.3% | 78% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $2 | $2 | $4 |
| SG&A Expenses | $1 | $2 | $2 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $3 | $2 | $5 |
| Operating Income | -$1 | -$2 | -$2 | -$4 |
| % Margin | -181% | -153.1% | -139.5% | -418.8% |
| Other Income/Exp. Net | -$0 | -$1 | -$2 | -$5 |
| Pre-Tax Income | -$1 | -$3 | -$3 | -$8 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$3 | -$3 | -$8 |
| % Margin | -219.6% | -195.8% | -301.6% | -934.6% |
| EPS | -0.002 | -0.007 | -0.027 | -0.24 |
| % Growth | 71.4% | 73.9% | 88.8% | – |
| EPS Diluted | -0.002 | -0.007 | -0.027 | -0.24 |
| Weighted Avg Shares Out | 649 | 377 | 134 | 51 |
| Weighted Avg Shares Out Dil | 649 | 377 | 134 | 51 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $1 | $3 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$2 | -$3 | -$5 |
| % Margin | -172.2% | -127.7% | -230.9% | -567% |